Transvaginal rectocele repair with human dermal allograft interposition and bilateral sacrospinous fixation with a minimum eight-year follow-up

Table 3 Patient Demographics (n = 41)

Mean Age (yrs)	60.6 ± 16.3
Mean Follow-up (months)	116.5 ± 18.9
Mean Parity	2.6 ± 2.37
Mean Body Mass Index	34.4 ± 6.1
Smoker (percent)	34.1
Menopausal (percent)	65.3
Post-Hysterectomy (percent)	41.4
Hormone Replacement (percent)	40.9
Sexually active (percent)	24.1
Previous Pelvic Surgery (percent)	70.0
Mean Preoperative A (p)(centimeters)^a	0.95 ± 0.70
Mean Postoperative A (p) (centimeters)^a	−1.90 ± 0.52
Mean Preoperative B (p)(centimeters)^a	1.30 ± 0.84
Mean Postoperative B (p)(centimeters)^a	−2.13 ± 0.51
Mean PreOp PFDI-20 (/300)^a	129.6 ± 26.7 (78–223)
Mean PostOp PFDI-20 (/300)^a	60.9 ± 18.4 (32–108)
Biological erosion (percent)	7.3
De novo dyspareunia (percent)	17.0
Complication rate (percent)	12.1
Patient satisfaction (percent)^b	77.0
Prolapse Failure Rate (percent)^c	27.0
Time to Prolapse Failure (months)	24.7 ± 15.3

^aChanges between pre- and postoperative Pelvic Floor Distress Inventory (PFDI-20, n = 41) and A(p) and B(p) were statistically significant at p = <0.001 at the time of patients’ last follow-up
^bA 7 point Likert Global Response Scale was used, whereby responses five, six and seven were deemed successful. Numbers 1–4 were judged as failures. The 77 % satisfaction rate includes only the former and not the latter
^cEleven prolapse failures: 7 Stage 2 (ICS), 3 Stage 3, and 1 Stage 4

ISSN: 1471-2490